Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 235-244

  Newell, David W ^a   Barth, Alain ^a   Ricciardi, Tom N ^a   Malouf, Alfred T ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; HIPPOCAMPUS; NERVE CELL LESION; NERVE EXCITABILITY; NEUROTOXICITY; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 0031149427     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6463     Document Type: Article

References (58)

1. Benveniste H., Drejer J., Schousboe A., Diemer N. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
2. Bolender R. P., Charlston J., Mottet K., McCabe J. T. Quantitative morphology of the nervous system: expanding horizons. Anat. Rec. 231:1991;407-415.
3. Brown A. W., Brierly J. B. Anoxic-ischemic cell change in rat brain light microscopic and fine-structural observations. J. Neurol. Sci. 16:1972;59-84.
4. Buchan A. M. Do NMDA antagonists protect against cerebral ischemia: Are clinical trials warranted. Cerebrovasc. Brain Metab. Rev. 2:1990;1-26.
5. Cai S., Dinsmore C., Gee K., Glenn A., Huang J., Johnson B., Kher S., Lu Y., Oldfield P., Marek P., Zheng H., Weber E., Keana J. Synthesis and activity of substituted quinoxaline-2,3-diones as antagonists for the glycine/NMDA receptor (abstract). J. Neurosci. 19:1993;296.11.
6. Choi D. W. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2:1990;105-147.
7. Curtis D. R., Hosli L., Johnston G. A. R., Johnston I. H. The hyperpolarization of spinal motorneurones by glycine and related amino acids. Exp. Brain Res. 5:1968;235-258.
8. Curtis D. R., Duggan A. W., Johnston G. A. R. The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp. Brain Res. 12:1971;547-565.
9. Daly E. C., Aprison M. H. Glycine. Handbook of Neurochemistry. 1983;Plenum, New York. p. 467-499.
10. de Groot C. J., Boeli Everts V., Touwen B. C. L., Hommes F. A. Non-ketotic hyperglycinemia (NKH): An inborn error of metabolism affecting brain function exclusively. Prog. Brain Res. 48:1978;199-205.
11. Dugan L. L., Bruno V. M. G., Amagasu S. M., Giffard R. G. Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity. J. Neurochem. 15:1995;4545-4555.
12. Gahwiler B. H. Development of hippocampus in vitro: cell types, synapses and receptors. Neuroscience. 11:1984;751-760.
13. Gemba T., Oshima T., Ninomiya M. Glutamate efflux via the reversal of the sodium-dependant glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience. 63:1994;789-795.
14. Globus M. Y-T., Ginsberg M. D., Busto R. Excitotoxic index - A biochemical marker of selective vulnerability. Neurosci. Lett. 127:1991;39-42.
15. Globus M. Y.-T., Busto R., Martinez E., Valdes I., Dietrich W. D., Ginsberg M. D. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and y-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J. Neurochem. 57:1991;470-478.
16. Hagberg H., Lehmann A., Sandberg M., Nystrom B., Jacobson I., Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J. Cereb. Blood Flow Metab. 5:1985;413-419.
17. 452+. J. Neurosci. 13:1993;1993-2000.
18. Heimrich B., Frotscher M. Differentiation of dentate granule cells in slice cultures of rat hippocampus: A Glogi/electron microscope study. Brain Res. 538:1991;263-268.
19. Huettner J. E. Indole-2-carboxylic acid: A competitive antagonist of potentiation by glycine at the NMDA receptor. Science. 243:1989;1611-1613.
20. 3. Brain Res. 482:1989;174-178.
21. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
22. Kemp J. A., Foster A. C., Lesson P. D., Priestley T., Tridgett R., Iversen L. L., Woodruff G. N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. Natl. Acad. Sci. USA. 85:1988;6547-6550.
23. Kleckner N. W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed inXenopus. Science. 241:1988;444-449.
24. Kleckner N. W., Dingledine R. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Mol. Pharmacol. 36:1989;430-436.
25. Larson A. A., Beitz A. J. Glycine potentiates strychnine-induced convulsions: Role of NMDA receptors. J. Neurosci. 8:1988;3822-3826.
26. Levi G., Bernardi G., Cherubini E., Gallo V., Marciani M. G., Stanzione P. Evidence in favor of a neurotransmitter role of glycine in the rat cerebral cortex. Brain Res. 236:1982;121-131.
27. Macklis J. D., Madison R. D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiologic status: a fluorescence scale of membrane integrity. J. Neurosci. Methods. 31:1990;43-46.
28. McNamara D., Dingledine R. Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. J. Neurosci. 10:1990;3970-3976.
29. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
30. McGeer P. L., McGeer E. G. Amino acid neurotransmitters. Siegel G. J., Agranoff B. W., Albers R. W., Molinoff P. B. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 1989;311-332 Raven Press, New York.
31. Newell D. W., Malouf A. T., Franck J. Glutamate mediated selective vulnerability to ischemia is present in organotypic cultures of hippocampus. Neurosci. Lett. 116:1990;325-330.
32. Newell D. W., Hsu S. S., Papermaster V., Malouf A. T. Colchicine is selectively neurotoxic to dentate granule cells in organotypic cultures of rat hippocampus. Neurotoxicology. 14:1993;375-380.
33. Newell D. W., Barth A., Malouf A. T. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures. Brain Res. 675:1995;38-44.
34. Newell D. W., Barth A., Papermaster V., Malouf A. T. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J. Neurosci. 15:1995;7702-7711.
35. Obrenovitch T. P., Richards D. A. Extracellular neurotransmitter changes in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 7:1995;1-54.
36. Oliver M. W., Kessler M., Larson J., Schottler F., Lynch G. Glycine site associated with the NMDA receptor modulates long-term potentiation. Synapse. 5:1990;265-270.
37. Pace J. R., Martin B. M., Paul S. M., Rogawaski M. A. High concentrations of neutral amino acids activate NMDA receptor currents in rat hippocampal neurons. Neurosci. Lett. 141:1992;97-100.
38. Patel J., Zinkand W. C., Thompson C., Keith R., Salama A. Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J. Neurochem. 54:1990;849-854.
39. Perry T. L., Hansen S. Amino acid abnormalities in epileptic foci. Neurology. 31:1981;872-876.
40. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
41. Schmidt-Kastner R., Freund T. F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
42. Shahi K., Baudry M. Glycine-induced changes in synaptic efficacy in hippocampal slices involve changes in AMPA receptors. Brain Res. 627:1993;261-266.
43. Shahi K., Marvizon J-C., Baudry M. High concentrations of glycine induce long-lasting changes in synaptic efficacy in rat hippocampal slices. Neurosci. Lett. 149:1993;185-188.
44. Siesjo B., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
45. Siesjo B. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J. Neurosurg. 77:1992;337-354.
46. Stoppini L., Buchs P-A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
47. Thomson A. M. Glycine is a coagonist at the NMDA receptor/channel complex. Prog. Neurobiol. 35:1990;53-74.
48. Torp R., Haug F. M., Tonder N. Neuroactive amino acids in organotypic slice cultures of the rat hippocampus: an immunocytochemical study of the distribution of GABA, glutamate, glutamine and taurine. Neuroscience. 46:1992;807-823.
49. Uckele J. E., McDonald J. W., Johnston M. V., Silverstein F. S. Effect of glycine and glycine receptor antagonists on NMDA-induced brain injury. Neurosci. Lett. 106:1989;279-283.
50. Vornov J. J., Tasker R. C., Coyle J. T. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp. Neurol. 114:1991;11-22.
51. Vornov J. J., Coyle J. T. Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J. Neurochem. 56:1991;996-1006.
52. Vornov J. J., Coyle J. T. Enhancement of NMDA receptor-mediated neurotoxicity in the hippocampal slice by depolarization and ischemia. Brain Res. 555:1991;99-106.
53. Wallis R. A., Panizzon K. L., Nolan J. P. Glycine-induced CA1 excitotoxicity in the rat hippocampal slice. Brain Res. 664:1994;115-125.
54. Warner D. S., Martin H., Ludwig P., McAllister A., Keana J. F. W., Weber E. In-vivo models of cerebral ischemia: Effects of parenterally administered glycine receptor antagonists. J. Cereb. Blood Flow Metab. 15:1995;188-196.
55. Werman R., Davidoff R. A., Aprison M. H. Inhibition of motorneurons by iontophoresis of glycine. Nature. 214:1967;681-683.
56. Wood E. R., Bussey T. J., Phillips A. G. A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits. Neuroreport. 4:1993;151-154.
57. Yoneda Y., Ogita K., Suzuki T. Interaction of strychnine-insensitive glycine binding with MK-801 binding in brain synaptic membranes. J. Neurochem. 55:1990;237-244.
58. Zafra F., Aragon C., Olivares L., Danbolt N. C., Giminez C., Storm-Mathisen J. Glycine transporters are differently expressed among CNS cells. J. Neurosci. 15:1995;3952-3969.